Mavrilimumab (CAM 3001) is a monoclonal antibody with antiviral activity that targets the alpha subunit of the granulocytic-macrophage colony-stimulating factor (GM-CSF) receptor, inhibiting downstream intracellular GM-CSF signaling. GM-CSF may contribute to an overactive inflammatory response linked to respiratory failure and death and could be used to study rheumatoid arthritis.
Purity:
>95%
CAS Number:
[1085337-57-0]
Target:
c-Fms|||CSF-1R|||Virus Protease
* VAT and and shipping costs not included. Errors and price changes excepted
